Lupin Launches Ajaduo M Forte, a Triple Fixed-Dose Combination of Empagliflozin, Linagliptin, and Metformin Extended Release (ER) MDTV Bureau31 March 2025 10:15 AM ISTGlobal pharmaceutical company Lupin Limited has announced the launch of Ajaduo M Forte, a novel triple fixed-dose combination (FDC) therapy for the...
Lupin three senior executives to retire in 2 days Ruchika Sharma29 March 2025 12:15 PM ISTMumbai: Global pharmaceutical giant Lupin has announced the retirement of its three senior executives.Naresh Gupta, President – API Plus &...
Lupin awarded EcoVadis Silver Medal for sustainability excellence Ruchika Sharma21 March 2025 2:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has been awarded "Silver Medal" by EcoVadis for its outstanding sustainability...
Lupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine Ruchika Sharma17 March 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin Launches Empagliflozin Linagliptin FDC, AjaDuo At Affordable Prices MD Brand Connect12 March 2025 10:00 AM ISTMumbai, [12/03/2025]: Global pharmaceutical leader Lupin Limited has announced the launch of Ajaduo, its fixed-dose combination (FDC) therapy for the...
Accelerating Action for Women's Health - Ft Rajeev Sibal, President, IRF, Lupin Limited Rajeev Sibal8 March 2025 5:33 PM ISTWomen's health is a multifaceted issue, shaped by socioeconomic factors, cultural influences, and evolving healthcare landscapes. In India, young...
Lupin unveils heart drug Rivaroxaban in US Ruchika Sharma8 March 2025 11:41 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of...
Lupin secures place in Prestigious S&P Global Sustainability Yearbook 2025 Ruchika Sharma2 March 2025 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced its inclusion in prestigious S&P Global Sustainability Yearbook 2025, for the second...
Lupin Gets Rs 18 Crore Relief as HC Bars Arbitrary Tax Reassessment Farhat Nasim22 Feb 2025 4:28 PM ISTMumbai: In a major relief to pharma giant Lupin Limited, the Bombay High Court has quashed a reassessment notice issued under Section 148 of the...
USFDA issues EIR for Lupin Somerset facility Ruchika Sharma22 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has issued the...
Lupin bags USFDA nod for Ipratropium Bromide Nasal Solution for rhinorrhea Ruchika Sharma11 Feb 2025 10:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
Natco Pharma gets final approval for Bosentan tablets for oral suspension Ruchika Sharma10 Feb 2025 11:30 AM ISTHyderabad: NATCO Pharma Limited has announced final approval of its Abbreviated New Drug Application (ANDA) for Bosentan tablets for oral...
